March 18, 2013 – Sanford Rose Associates- San Diego has placed Thomas McLain as president and chief executive officer of Vermillion, Inc. Mr. McLain recently served as both CEO and CFO of Claro Scientific, LLC, an innovative early stage diagnostic company. Robin Toft, president and CEO of Sanford Rose Associates – San Diego, said: “Mr. McLain is a dynamic leader with 15 years experience as a president and CEO of both publicly traded and privately held venture growth companies focused on laboratory services, biopharmaceutical, biotechnology and healthcare services. He will be a valuable asset as Vermillion focuses on their global commercialization efforts.” Sanford Rose Associates- San Diego provides specialized in building management teams for personalized medicine, molecular diagnostic and oncology companies.
Share This Article